BASP1 is up-regulated in tongue squamous cell carcinoma and associated with a poor prognosis.

[1]  Yan Yu,et al.  High BASP1 Expression is Associated with Poor Prognosis and Promotes Tumor Progression in Human Lung Adenocarcinoma , 2021, Cancer investigation.

[2]  P. Persson,et al.  Podocyte apoptosis in diabetic nephropathy by BASP1 activation of the p53 pathway via WT1 , 2021, Acta physiologica.

[3]  Li Li,et al.  BASP1 Suppresses Cell Growth and Metastasis through Inhibiting Wnt/β-Catenin Pathway in Gastric Cancer , 2020, BioMed research international.

[4]  A. Ram,et al.  Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma , 2020, Asian Pacific journal of cancer prevention : APJCP.

[5]  M. Ladomery,et al.  WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1. , 2020, Biochimica et biophysica acta. Gene regulatory mechanisms.

[6]  K. Omori,et al.  Outcomes in patients diagnosed with tongue cancer before and after the age of 45 years. , 2020, Oral oncology.

[7]  Rinus G. Verdonschot,et al.  Intraoral Ultrasonographic Features of Tongue Cancer and the Incidence of Cervical Lymph Node Metastasis. , 2020, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[8]  G. Caraveo,et al.  GAP-43 and BASP1 in Axon Regeneration: Implications for the Treatment of Neurodegenerative Diseases , 2020, Frontiers in Cell and Developmental Biology.

[9]  Weiping Zhou,et al.  miR-515-5p suppresses HCC migration and invasion via targeting IL6/JAK/STAT3 pathway. , 2020, Surgical oncology.

[10]  Wei-Chung Cheng,et al.  Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression , 2020, Theranostics.

[11]  J. Turkson,et al.  27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6–JAK–STAT3 Signaling in Prostate Cancer Cells , 2020, Molecular Cancer Research.

[12]  M. Hartl,et al.  The brain acid‐soluble protein 1 (BASP1) interferes with the oncogenic capacity of MYC and its binding to calmodulin , 2020, Molecular oncology.

[13]  M. Hennequin,et al.  Impairments in Food Oral Processing in Patients Treated for Tongue Cancer , 2019, Dysphagia.

[14]  G. Marko‐Varga,et al.  Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue , 2019, EBioMedicine.

[15]  Haoying Yang,et al.  Overexpression of miR-574-3p suppresses proliferation and induces apoptosis of chronic myeloid leukemia cells via targeting IL6/JAK/STAT3 pathway. , 2018, Experimental and therapeutic medicine.

[16]  Xiaodong Zhang,et al.  Methylation-associated silencing of BASP1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia , 2018, Experimental & Molecular Medicine.

[17]  Wei R. Chen,et al.  High brain acid soluble protein 1(BASP1) is a poor prognostic factor for cervical cancer and promotes tumor growth , 2017, Cancer Cell International.

[18]  J. Heiss,et al.  B7-H4(B7x)–Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients , 2016, Clinical Cancer Research.

[19]  T. Lister,et al.  Assignment1 of brain acid-soluble protein 1 (BASP1) to human chromosome 5p15.1→p14, differential expression in human cancer cell lines as a result of alterations in gene dosage , 2000, Cytogenetic and Genome Research.